Company news

EVE Health Group Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Quarterly Activities/Appendix 5B Cash Flow Report

October 23, 2024

Preliminary Final Report

August 30, 2024

Sale of Robyndale Property (Amended)

August 30, 2024

Sale of Robyndale Property

August 30, 2024

Sale of Jendale Property

April 29, 2024

Farm Sale and Funding Update

January 31, 2024

Appendix 4E - Results for Announcement to the Market

August 30, 2023

Appendix 4C - December Quarter 2022

January 31, 2023

Appendix 4C - September Quarter 2022

October 25, 2022

Appendix 4E and Preliminary Final Report

August 31, 2022

Appendix 4C - June Quarter 2022

July 27, 2022

Rights Issue Offer Document

June 5, 2022

Non-Renounceable Rights Offer

May 29, 2022

Notification regarding unquoted securities - EVE

May 2, 2022

Appendix 4C - March Quarter 2022

April 29, 2022

Update - Proposed issue of securities - EVE

April 20, 2022

Application for quotation of securities - EVE

February 27, 2022

$1.4m Share Placement

February 21, 2022

Appendix 4C - December Quarter 2021

January 31, 2022

Meluka Australia - Half Year Update

January 19, 2022

Change of Director's Interest Notice x 3

January 3, 2022

Alliance Agreement - Additional Information

December 6, 2021

Alliance Agreement - Australian Sales Force

December 5, 2021

Appendix 4C - September Quarter 2021

October 29, 2021

New Probiotic Product Range - Additional Information

October 19, 2021

Meluka Sales Performance Drives New Probiotic Product Range

October 18, 2021

Appendix 4C - June Quarter 2021 - Amended

August 5, 2021

Appendix 4C - June Quarter 2021

July 29, 2021

Appendix 4C - March Quarter 2021

April 29, 2021

Company Update

April 14, 2021

Appendix 4C - December Quarter 2020

January 27, 2021

Omni Innovation Enters Licencing Agreement

January 13, 2021

Appendix 4C - September Quarter 2020

October 18, 2020

Appendix 4C - June Quarter 2020

July 12, 2020

Appendix 4C - March Quarter 2020

April 15, 2020

Market Update - COVID-19 and operations

March 25, 2020

Quarterly Review

January 30, 2020

Tranche 1 Placement Funds Received

December 5, 2019

Reinstatement to Official Quotation

December 5, 2019

Voluntary Suspension

November 28, 2019

$9.3m Strategic Placement

October 6, 2019

Suspension from Official Quotation

September 29, 2019

Capital Raising Update

August 9, 2019

EVE Placement Raises $750k

July 12, 2019

Pause in Trading

July 11, 2019

Response to Appendix 4C Query

May 20, 2019

THC Global Agreement Update

May 14, 2019

Meluka Honey Secures Distribution for Northern NSW & SEQ

April 2, 2019

Placement

March 25, 2019

Meluka Honey Appoints OpenDNA for Chinese Market Entry

March 11, 2019

← Newer news releases · Older news releases →

Decks

The 5 newest of 34 decks. Every deck is listed under its year.